Evotec Wins € 7.5 Mill Grant for Development of First-in-class COVID-19 Therapeutic
Evotec, a publicly listed drug discovery and development company, has won a € 7.5 million grant for the development of
Read more
Drug Development
Genentech’s Investigational Antibody Wins BTD for Alzheimer’s Treatment
Genentech’s investigational antibody for the treatment of early-stage Alzheimer’s disease, Gantenerumab, has been granted Breakthrough Therapy Designation by the U.S.
Read more
Tezepelumab gets ODD in the US for Eosinophilic Esophagitis
Tezepelumab, developed by AstraZeneca in collaboration with Amgen, has been granted Orphan Drug Designation (ODD) in the US FDA for
Read more
Takeda and JCR to Commercialize Next-Gen Hunter Syndrome Therapy
Takeda and JCR Pharmaceuticals announced today a geo-based exclusive collaboration and license agreement to commercialize JR-141 (INN: pabinafusp alfa), an
Read more
Boehringer Ingelheim and Twist Form Therapeutic Antibody Discovery Partnership
Boehringer Ingelheim and Twist Bioscience have entered into a research collaboration that covers multiple antibody research programs. Twist Bioscience Corporation,
Read more
Vertex and Arbor Collaborate to Develop Novel ex vivo Engineered Cell Therapies
Vertex Pharmaceuticals Incorporated and Arbor Biotechnologies unveiled they have entered into a new cooperation to accelerate the development of novel
Read more
Novel Lipases of Microbial Origin for Superior Performance
Novel lipases of microbial origin selected and engineered for best performance. A EUCODIS Bioscience Case Study EUCODIS Bioscience offers a
Read more
Arvinas and Pfizer to Co-develop and Commercialize Breast Cancer Therapy
Arvinas and Pfizer have announced a global collaboration to develop and commercialize ARV-471, an investigational oral PROTAC® (PROteolysis TArgeting Chimera)
Read more
SARS-CoV-2 Main Protease (Mpro) from Biosynth
The main protease (Mpro) is a key enzyme of SARS-CoV-2 and is required for viral replication and transcription. A Biosynth
Read more
Lilly and MiNA Therapeutics to Collaborate on saRNA Research
Eli Lilly and Company and MiNA Therapeutics, a pioneer in RNA activation therapeutics, have announced a worldwide research partnership to
Read more